More News

09 Jan 2017 Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases
09 Jan 2017 Ferring Partners with Intralytix to Develop Bacteriophage Treatments for Conditions Associated with the Microbiome and Drug-Resistant Bacteria
09 Jan 2017 AbbVie Announces Four New Global Research Collaborations Focused on Advancing Next-Generation Science
09 Jan 2017 Anokion Announces Exclusive Strategic Collaboration With Celgene to Develop Novel Tolerance-Inducing Therapeutics for Autoimmune Diseases
09 Jan 2017 AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekynda™ (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder
09 Jan 2017 EMD Serono and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration
09 Jan 2017 Takeda to Acquire ARIAD Pharmaceuticals, Inc.
09 Jan 2017 Sierra Oncology Successfully Transfers Sponsorship of SRA737 Clinical Trials
09 Jan 2017 Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds
09 Jan 2017 Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs
09 Jan 2017 Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
09 Jan 2017 Merrimack Concludes Strategic Review; Announces Plan to Divest Assets and Sharpen Strategic Focus
09 Jan 2017 Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
09 Jan 2017 Mast Therapeutics And Savara Sign Merger Agreement
07 Jan 2017 Viriom Announces Collaboration with NIH on Zika and Other Major Viral Diseases
07 Jan 2017 HepaRegeniX GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases
07 Jan 2017 Lin Bioscience Licenses First-in-Class Therapeutic Program to treat Dry Aged-Related Macular Degeneration from Columbia University in Collaboration with NIH
07 Jan 2017 SiteOne Therapeutics Announces Research and Development Agreement With Amgen to Advance Portfolio of Highly Selective, Potent Inhibitors of NaV1.7 for Acute and Chronic Pain
07 Jan 2017 BioAtla and F1 Oncology Announce Global Collaboration to Develop Adoptive Cellular Therapies for Solid Tumors
06 Jan 2017 OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement
06 Jan 2017 Cerveau Technologies, Inc. Signs License Agreement with Merck for Novel Investigational Tau Imaging Agent
06 Jan 2017 Momenta and CSL Announce Collaboration and License Agreement to Develop Fc Multimer Programs, Including M230, a Selective Immunomodulator of Fc Receptors
06 Jan 2017 Ionis and Akcea Enter into Strategic Collaboration with Global Pharmaceutical Company to Develop and Commercialize AKCEA-APO(a)-L Rx and AKCEA-APOCIII-L Rx
05 Jan 2017 Avidity Biosciences Raises $16 Million in Series B Financing to Advance Antibody-siRNA Conjugate Platform
05 Jan 2017 TOT BIOPHARM and LEE'S PHARM Signed an Exclusive Licensing Agreement on Monoclonal Antibody Drug TAB014

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing